The national vaccination panel has updated the recommendations for use of Corona vaccine. It now states that cross-vaccination is also possible under certain circumstances.
A vaccine switch should be offered if those vaccinated suffered severe side effects after the first dose. Also, if a switch is “strongly desirable from the point of view of the person to be vaccinated,” it will be made possible.
First vector, then mRNA
In Germany, the Standing Commission on Vaccination (STIKO) already came out in favor of cross-vaccination on July 1. Here, it was specified that the change would primarily affect those who were first vaccinated with a vector vaccine such as AstraZeneca.
They should receive an mRNA vaccine from Pfizer/Biontech or Moderna for their second vaccination. This increases efficacy compared to two doses of a vector vaccine, experts say.
— source: futurezone.at/picture: pixabay.com
This post has already been read 898 times!